Services search (in the department)
Illness | Number of cases |
---|---|
Obstructive and reflux uropathy - Hydronephrosis with ureteral stricture not elsewhere classified (N13.1) | 10 |
Malignant neoplasm of bladder - Malignant neoplasm of overlapping sites of bladder (C67.8) | 8 |
Obstructive uropathy and refluxuropathy - Hydronephrosis in obstruction by renal and ureteral calculi - Hydronephrosis in obstruction by ureteral calculi (N13.21) | 5 |
Calculus of kidney and ureter - Calculus of ureter (N20.1) | 5 |
Malignant neoplasm of bladder - Malignant neoplasm of dome of bladder (C67.1) | 4 |
Hyperplasia of prostate (N40) | 4 |
Redundant prepuce phimosis and paraphimosis (N47) | 4 |
Malignant neoplasm of prostate (C61) | not specified |
Malignant neoplasm of bladder - Malignant neoplasm of trigone of bladder (C67.0) | not specified |
Malignant neoplasm of bladder - Malignant neoplasm of lateral wall of bladder (C67.2) | not specified |
Treatment | Number |
---|---|
Injection or administration of medicines into the urinary bladder (8-132.3) | 26 |
Surgical incision, removal or destruction of diseased tissue in the urinary bladder, with access through the urethra (5-573.41) | 21 |
X-rays of the kidney and urinary tract with contrast medium (3-13d.5) | 19 |
Use of an imaging procedure during an operation (3-992) | 19 |
Surgical incision, removal or destruction of diseased tissue in the urinary bladder, with access through the urethra (5-573.40) | 12 |
Dilatation of the ureters during an operation or endoscopy (5-560.3x) | 11 |
Instillation into a body cavity and locally restricted treatment with chemotherapy drugs or agents that influence the immune system (8-541.4) | 9 |
Surgical incision, removal or destruction of diseased tissue in the urinary bladder, with access through the urethra (5-573.1) | 5 |
Surgical removal or destruction of prostatic tissue through the urethra (5-601.0) | 5 |
Insertion, exchange or removal of a ureteral stent (8-137.00) | 5 |
Department key: 2290
Inpatient department
Umfasst die Behandlung des diabetischen Fußsyndroms z. B. Durchführung von Patientenschulungen nach § 3 Abs. 5 Nr. 1.
Number | Group |
---|---|
20 | Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training* |
13 | Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence |
13 | Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations |
Job | Explanation |
---|---|
Student training (clinical traineeship / internship year) |
No. | Training in other healing professions | Comment |
---|---|---|
HB15 | Anaesthesia technical assistant (m/f) | In Kooperation mit dem Klinikum Nürnberg. |
HB17 | Auxiliary nurse (m/f) | In Kooperation mit dem Klinikum Nürnberg. |
HB07 | Surgical technical assistant (m/f) | In Kooperation mit dem Klinikum Nürnberg. |
HB19 | Nursing professionals | In Kooperation mit dem Klinikum Nürnberg |
HB01 | Nurse and health care worker (m/f) | In Kooperation mit dem Klinikum Nürnberg. |
Annett Baumann
Phone:
09123180295
--
Mail:
ed.grebnreun-mukinilk@nnamuaB.ttennA
Sabrina Hartmann
Referentin der Geschäftsführung
Phone:
09123
-180-161
Mail:
ed.fual-hk@nnamtrah.anirbas
Dr. Susanne Rudisch
Chefärztin der Allgemein- und Viszeralchirurgie
Phone:
09123
-180-278
Mail:
ed.fual-hk@fual-eigrurihclarezsiv
Dr. Annette Sattler
Leitende Apothekerin
Phone:
0911
-3982550-
Mail:
ed.grebnreun-mukinilk@relttas.ettennA